NEKTAR THERAPEUTICS Annual Return On Equity in % from 2011 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Nektar Therapeutics quarterly/annual Return On Equity history and growth rate from 2011 to 2023.
  • Nektar Therapeutics Return On Equity for the quarter ending September 30, 2024 was -174 %, a 43% decline year-over-year.
  • Nektar Therapeutics annual Return On Equity for 2023 was -152 %, a 90% decline from 2022.
  • Nektar Therapeutics annual Return On Equity for 2022 was -79.8 %, a 28.8% decline from 2021.
  • Nektar Therapeutics annual Return On Equity for 2021 was -62 %, a 67.4% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -152 -71.8 -90% Jan 1, 2023 Dec 31, 2023
2022 -79.8 -17.8 -28.8% Jan 1, 2022 Dec 31, 2022
2021 -62 -25 -67.4% Jan 1, 2021 Dec 31, 2021
2020 -37 -8.06 -27.8% Jan 1, 2020 Dec 31, 2020
2019 -29 -79.2 -158% Jan 1, 2019 Dec 31, 2019
2018 50.2 +226 Jan 1, 2018 Dec 31, 2018
2017 -176 -3.37K -106% Jan 1, 2017 Dec 31, 2017
2016 3.19K +3.4K Jan 1, 2016 Dec 31, 2016
2015 -206 +356 +63.4% Jan 1, 2015 Dec 31, 2015
2014 -562 -915 -259% Jan 1, 2014 Dec 31, 2014
2013 354 +511 Jan 1, 2013 Dec 31, 2013
2012 -157 -102 -182% Jan 1, 2012 Dec 31, 2012
2011 -55.8 Jan 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.